3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
9
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Pathologic Complete Response
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
pembrolizumab
8
Carboplatin
6
Cyclophosphamide
5
veliparib
4
olaparib
4
Magnetic Resonance Spectroscopy
4
liposomal doxorubicin
3
Taxes
3
Paclitaxel
3
Gene Expression Profiling
3
Gemcitabine
3
palbociclib
2
niraparib
2
fludarabine
2
durvalumab
2
Temozolomide
2
Specimen Handling
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Interleukin-2
2
Fulvestrant
2
Fluorouracil
2
Early Intervention, Educational
2
Drug Therapy
2
Doxorubicin
2
Biopsy
2
130-nm albumin-bound paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Patient Reported Outcome Measures
×
Breast
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled